117 related articles for article (PubMed ID: 31846633)
21. Cooperation between Myc and YY1 provides novel silencing transcriptional targets of alpha3beta1-integrin in tumour cells.
de Nigris F; Botti C; Rossiello R; Crimi E; Sica V; Napoli C
Oncogene; 2007 Jan; 26(3):382-94. PubMed ID: 16878156
[TBL] [Abstract][Full Text] [Related]
22. The Multilayered Regulation of the Oncogenic Protein YY1.
Rizkallah R; Hurt MM
Crit Rev Oncog; 2017; 22(1-2):109-129. PubMed ID: 29604940
[TBL] [Abstract][Full Text] [Related]
23. The role of YY1 in oncogenesis and its potential as a drug target in cancer therapies.
Shi J; Hao A; Zhang Q; Sui G
Curr Cancer Drug Targets; 2015; 15(2):145-57. PubMed ID: 25817371
[TBL] [Abstract][Full Text] [Related]
24. Therapeutic YY1 Inhibitors in Cancer: ALL in ONE.
Bonavida B
Crit Rev Oncog; 2017; 22(1-2):37-47. PubMed ID: 29604935
[TBL] [Abstract][Full Text] [Related]
25. Yin Yang 1 is associated with cancer stem cell transcription factors (SOX2, OCT4, BMI1) and clinical implication.
Kaufhold S; Garbán H; Bonavida B
J Exp Clin Cancer Res; 2016 May; 35():84. PubMed ID: 27225481
[TBL] [Abstract][Full Text] [Related]
26. Histone deacetylase inhibitors suppress mutant p53 transcription via HDAC8/YY1 signals in triple negative breast cancer cells.
Wang ZT; Chen ZJ; Jiang GM; Wu YM; Liu T; Yi YM; Zeng J; Du J; Wang HS
Cell Signal; 2016 May; 28(5):506-515. PubMed ID: 26876786
[TBL] [Abstract][Full Text] [Related]
27. Interplay between heme oxygenase-1 and the multifunctional transcription factor yin yang 1 in the inhibition of intimal hyperplasia.
Beck K; Wu BJ; Ni J; Santiago FS; Malabanan KP; Li C; Wang Y; Khachigian LM; Stocker R
Circ Res; 2010 Dec; 107(12):1490-7. PubMed ID: 21030713
[TBL] [Abstract][Full Text] [Related]
28. Yin Yang 1-mediated epigenetic silencing of tumour-suppressive microRNAs activates nuclear factor-κB in hepatocellular carcinoma.
Tsang DP; Wu WK; Kang W; Lee YY; Wu F; Yu Z; Xiong L; Chan AW; Tong JH; Yang W; Li MS; Lau SS; Li X; Lee SD; Yang Y; Lai PB; Yu DY; Xu G; Lo KW; Chan MT; Wang H; Lee TL; Yu J; Wong N; Yip KY; To KF; Cheng AS
J Pathol; 2016 Apr; 238(5):651-64. PubMed ID: 26800240
[TBL] [Abstract][Full Text] [Related]
29. Galiximab signals B-NHL cells and inhibits the activities of NF-κB-induced YY1- and snail-resistant factors: mechanism of sensitization to apoptosis by chemoimmunotherapeutic drugs.
Martinez-Paniagua MA; Vega MI; Huerta-Yepez S; Baritaki S; Vega GG; Hariharan K; Bonavida B
Mol Cancer Ther; 2012 Mar; 11(3):572-81. PubMed ID: 22267549
[TBL] [Abstract][Full Text] [Related]
30. Prognostic significance of YY1 protein expression and mRNA levels by bioinformatics analysis in human cancers: a therapeutic target.
Bonavida B; Kaufhold S
Pharmacol Ther; 2015 Jun; 150():149-68. PubMed ID: 25619146
[TBL] [Abstract][Full Text] [Related]
31. YY1 regulates cancer cell immune resistance by modulating PD-L1 expression.
Hays E; Bonavida B
Drug Resist Updat; 2019 Mar; 43():10-28. PubMed ID: 31005030
[TBL] [Abstract][Full Text] [Related]
32. Yin yang 1 (YY1) represses histidine decarboxylase gene expression with SREBP-1a in part through an upstream Sp1 site.
Ai W; Liu Y; Wang TC
Am J Physiol Gastrointest Liver Physiol; 2006 Jun; 290(6):G1096-104. PubMed ID: 16357063
[TBL] [Abstract][Full Text] [Related]
33. The Yin and Yang of YY1 in tumor growth and suppression.
Khachigian LM
Int J Cancer; 2018 Aug; 143(3):460-465. PubMed ID: 29322514
[TBL] [Abstract][Full Text] [Related]
34. Differential regulation of human YY1 and caspase 7 promoters by prohibitin through E2F1 and p53 binding sites.
Joshi B; Rastogi S; Morris M; Carastro LM; DeCook C; Seto E; Chellappan SP
Biochem J; 2007 Jan; 401(1):155-66. PubMed ID: 16918502
[TBL] [Abstract][Full Text] [Related]
35. Yin Yang 1 Dynamically Regulates Antiviral Innate Immune Responses During Viral Infection.
Zan J; Zhang H; Gu AP; Zhong KL; Lu MY; Bai XX; Zhang JY; Cai J
Cell Physiol Biochem; 2017; 44(2):607-617. PubMed ID: 29161701
[TBL] [Abstract][Full Text] [Related]
36. Zidovudine, abacavir and lamivudine increase the radiosensitivity of human esophageal squamous cancer cell lines.
Chen X; Wang C; Guan S; Liu Y; Han L; Cheng Y
Oncol Rep; 2016 Jul; 36(1):239-46. PubMed ID: 27220342
[TBL] [Abstract][Full Text] [Related]
37. Transcription Factor YY1 Modulates Lung Cancer Progression by Activating lncRNA-PVT1.
Huang T; Wang G; Yang L; Peng B; Wen Y; Ding G; Wang Z
DNA Cell Biol; 2017 Nov; 36(11):947-958. PubMed ID: 28972861
[TBL] [Abstract][Full Text] [Related]
38. Yin-Yang 1 and Yin-Yang 2 exert opposing effects on the promoter activity of interleukin 4.
Lee SH; Cho YC; Jeong HM; Kim KH; Choi HJ; Lee KY; Kang BY
Arch Pharm Res; 2016 Apr; 39(4):547-554. PubMed ID: 26345265
[TBL] [Abstract][Full Text] [Related]
39. OCT4-mediated transcription confers oncogenic advantage for a subset of gastric tumors with poor clinical outcome.
Pandian J; Panneerpandian P; Sekar BT; Selvarasu K; Ganesan K
Funct Integr Genomics; 2022 Dec; 22(6):1345-1360. PubMed ID: 35987846
[TBL] [Abstract][Full Text] [Related]
40. YY1 Is an Inducer of Cancer Metastasis.
Wang W; Li D; Sui G
Crit Rev Oncog; 2017; 22(1-2):1-11. PubMed ID: 29604932
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
